Deep Tech

Strategy Type

Equity

Typical Stage

Pre-Seed through Growth

Return Profile

Long-Horizon, High Variance

What It Is

Deep tech investing backs companies where the core risk is technical — whether the science works — rather than commercial. Fusion, quantum computing, novel materials, and therapeutics all fall in this category.

Development timelines are measured in years, sometimes a decade, which sits awkwardly with conventional fund lifecycles.

Typical Approach

Underwrite technical feasibility before market questions
Milestone-based funding tied to scientific progress
Longer fund lives or evergreen structures
Combine equity with government grants and non-dilutive funding
Deep technical diligence, often with external specialists

Return Drivers

Defensibility from patents and hard-won know-how
Very large markets if the technology succeeds
Scarcity of competitors able to replicate the science
Strategic acquisition interest from incumbents
Government and policy tailwinds in some sectors

Key Risks

The science may simply not work at commercial scale
Timelines routinely exceed projections
Capital requirements are large and sustained
Fewer investors are able to underwrite the technical risk
Regulatory pathways can be long and uncertain

What Founders Should Know

Deep tech founders should target investors who genuinely underwrite technical risk. A generalist fund that cannot evaluate the science will default to commercial metrics the company does not yet have.

Non-dilutive funding — grants, government programmes, strategic partnerships — often does more for a deep tech balance sheet than an additional equity round.

Looking for the right kind of capital?

Global Capital Network connects founders with investors whose strategy actually fits their business.

Explore Opportunities All Strategies